Serum DNase I soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficancy of hrDNase I treatment?

Creators: TINAZZI E; PUCCETTI, ANTONIO; GERLI R; RIGO A; MIGLIORINI P; SIMEONI S; BERI R; DOLCINO M; MARTINELLI N; CORROCHER R; LUNARDI C.

Others:: Tinazzi, E; Puccetti, Antonio; Gerli, R; Rigo, A; Migliorini, P; Simeoni, S; Beri, R; Dolcino, M; Martinelli, N; Corrocher, R; Lunardi, C.

Additional details